Anthropic announced an $83 IPO price on November 18. The offering comprises 980 million shares, including shares sold by the company and existing holders. Nasdaq trading is expected on November 19 under ANT, with the offering expected to close on November 20 subject to customary conditions. These are the milestones in the official release, not our confirmation of a first market trade.

Different numbers describe different things

Kaldata covers the broader financial context. Here, the specific official terms provide the verified foundation. Multiplying 980 million by $83 gives a gross size of $81.34 billion for the described shares. This is our arithmetic, not net proceeds received by Anthropic or the market capitalization of the entire company.

The release explicitly says selling shareholders' proceeds do not go to the company. That distinction matters: transaction volume, new capital and valuation are not interchangeable. We do not adopt broader amounts absent from the release as established outcomes.

Offering price and market price

Investor.gov's explanatory bulletin separates a negotiated IPO price from subsequent trading prices. It also explains the prospectus as a source on terms, use of proceeds and risks. This is general regulatory educational context, not an assessment of this particular stock.

Our editorial interpretation for the AI sector is to follow verifiable financial and operating disclosures after this milestone. New capital may support future plans, but a large amount alone establishes neither a better model nor cheaper service or a completed infrastructure schedule. Those questions need their own evidence.

What matters to Claude users

For an organization using an AI service, practical criteria remain availability, contractual terms, quality and the ability to move work elsewhere. These should be checked directly. A major financing event does not replace an application test or continuity plan.

Similarly, a stock ticker does not certify the quality of every automated action. Assessing the provider as a business and assessing a model for a task are related but distinct decisions. We recommend keeping separate evidence rather than reducing both to a headline number.

The verified news is the price and announced offering schedule. SIExpo provides neither a purchase recommendation nor a return forecast. A separate checked source would be needed to report an actual market price after trading begins.